These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 7454476)
21. [Reye syndrome: a case study in a Cuban provincial hospital from 1990 to 1996]. Viñas-Machín PL; Núñez-Díaz BC Rev Neurol; 1999 May 16-31; 28(10):959-61. PubMed ID: 10617371 [TBL] [Abstract][Full Text] [Related]
22. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome. Trost LC; Lemasters JJ Toxicol Appl Pharmacol; 1997 Dec; 147(2):431-41. PubMed ID: 9439738 [TBL] [Abstract][Full Text] [Related]
23. Reye's syndrome-like illness in a patient receiving amiodarone. Jones DB; Mullick FG; Hoofnagle JH; Baranski B Am J Gastroenterol; 1988 Sep; 83(9):967-9. PubMed ID: 3414648 [TBL] [Abstract][Full Text] [Related]
24. [Reye's syndrome in an adult following therapy with salicylates in Still's disease]. Tumiati B; Azzalito C; Veneziani M Medicina (Firenze); 1989; 9(1):64-5. PubMed ID: 2739536 [TBL] [Abstract][Full Text] [Related]
25. Salicylate and mitochondrial injury in Reye's syndrome. You K Science; 1983 Jul; 221(4606):163-5. PubMed ID: 6857275 [TBL] [Abstract][Full Text] [Related]
29. Aflatoxin and Reye's syndrome: a case control study. Nelson DB; Kimbrough R; Landrigan PS; Hayes AW; Yang GC; Benanides J Pediatrics; 1980 Dec; 66(6):865-9. PubMed ID: 7454477 [TBL] [Abstract][Full Text] [Related]
30. Chronic salicylism in a patient with juvenile rheumatoid arthritis. Everson GW; Krenzelok EP Clin Pharm; 1986 Apr; 5(4):334-41. PubMed ID: 3709082 [TBL] [Abstract][Full Text] [Related]
31. Preadmission antipyretics in Reye's syndrome. Hall SM; Plaster PA; Glasgow JF; Hancock P Arch Dis Child; 1988 Jul; 63(7):857-66. PubMed ID: 3415311 [TBL] [Abstract][Full Text] [Related]
32. Reye's syndrome and aspirin. Drug Ther Bull; 1984 Oct; 22(20):79-80. PubMed ID: 6489170 [No Abstract] [Full Text] [Related]
33. Is a compromised interferon response an etiologic factor in Reye's syndrome? Rozee KR; Lee SH; Crocker JF; Digout S; Arcinue E Can Med Assoc J; 1982 Apr; 126(7):798-802. PubMed ID: 6176306 [TBL] [Abstract][Full Text] [Related]
34. Scientific uncertainties in the studies of salicylate use and Reye's syndrome. Daniels SR; Greenberg RS; Ibrahim MA JAMA; 1983 Mar; 249(10):1311-6. PubMed ID: 6827709 [No Abstract] [Full Text] [Related]
35. Hepatic and cerebral pathology findings in children with fatal salicylate intoxication: further evidence for a causal relation between salicylate and Reye's syndrome. Starko KM; Mullick FG Lancet; 1983 Feb; 1(8320):326-9. PubMed ID: 6185805 [TBL] [Abstract][Full Text] [Related]
37. Confirmation of serum salicylate levels in Reye's syndrome: a comparison between the Natelson colorimetric method and high performance liquid chromatography. Clark JH; Nagamori K; Fitzgerald JF Clin Chim Acta; 1985 Feb; 145(3):243-7. PubMed ID: 3987027 [TBL] [Abstract][Full Text] [Related]
38. Impaired oxidative metabolism of salicylate in Reye's syndrome. Meert KL; Kauffman RE; Deshmukh DR; Sarnaik AP Dev Pharmacol Ther; 1990; 15(2):57-60. PubMed ID: 2078973 [TBL] [Abstract][Full Text] [Related]
40. Periportal hepatic necrosis in Reye's syndrome. One case in a review of eight patients. Bentz MS; Cohen C Am J Gastroenterol; 1980 Jan; 73(1):49-53. PubMed ID: 7377172 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]